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Abstract 
Purpose: To prospectively compare the diagnostic performance of low-dose 
computed tomography coronary angiography (CTCA) and cardiac magnetic 
resonance imaging (CMR) and combinations thereof for the diagnosis of significant 
coronary stenoses. 
Materials and Methods: Forty-three consecutive patients with known or suspected 
coronary artery disease underwent catheter coronary angiography (CA), dual-source 
CTCA with prospective electrocardiography-gating, and cardiac CMR (1.5 Tesla). 
The following tests were analyzed: 1) low-dose CTCA, 2) adenosine stress-rest 
perfusion-CMR, 3) late gadolinium enhancement (LGE), 4) perfusion-CMR and LGE, 
5) low-dose CTCA combined with perfusion-CMR, 5) low-dose CTCA combined with 
late gadolinium-enhancement, 6) low-dose CTCA combined with perfusion-CMR and 
LGE. CA served as the standard of reference. 
Results: CA revealed >50% diameter stenoses in 68/129 (57.7%) coronary arteries 
in 29/43 (70%) patients. In the patient-based analysis, sensitivity, specificity, NPV 
and PPV of low-dose CTCA for the detection of significant stenoses were 100%, 
92.9%, 100% and 96.7%, respectively. For perfusion-CMR and LGE, sensitivity, 
specificity, NPV, PPV, and accuracy were 89.7%, 100%, 82.4%, and 100%, 
respectively. In the artery-based analysis, sensitivity and NPV of low-dose CTCA was 
significantly (p<0.05) higher than that of perfusion-CMR and LGE. All combinations of 
low-dose CTCA and perfusion-CMR and/or LGE did not improve the diagnostic 
performance when compared to low-dose CTCA alone. 
Conclusion: Taking CA as standard of reference, low-dose CTCA outperforms CMR 
with regard to sensitivity and NPV, whereas CMR is more specific and has a higher 
PPV than low-dose CTCA. 
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Introduction 
Conventional coronary angiography (CA) represents the clinical standard of 
reference for the diagnosis and management of patients with known or suspected 
coronary artery disease (CAD). Nevertheless, non-invasive imaging modalities 
including nuclear tests [1], cardiac magnetic resonance imaging (CMR) [2], and 
computed tomography coronary angiography (CTCA) [3, 4] have challenged the role 
of the invasive standard. 
CTCA using single-source or dual-source 64-slice CT scanners has emerged 
as a robust and accurate tool for the non-invasive diagnosis of significant coronary 
stenoses. On the other hand, concerns regarding the radiation exposure of patients 
undergoing CTCA have been raised, which prompted various dose reducing 
algorithms. One of the most efficient techniques for radiation dose reduction in CTCA 
is prospective electrocardiography (ECG)-gating, where radiation is only delivered at 
selected time points of the cardiac cycle [5]. First studies have shown that the low-
dose technique for CTCA is accurate for the diagnosis of significant coronary 
stenoses as compared with CA [6]. Due to maintained diagnostic accuracy combined 
with the reduction of applied radiation dose, CTCA with prospective ECG-gating has 
become the standard method for CTCA in many centers [7].  
CMR represents an important modality for the indirect detection of CAD 
through demonstration of myocardial perfusion defects. Stress- and rest adenosine 
first pass perfusion-CMR with late gadolinium-enhancement (LGE) allows for the 
detection of both ischemic and ischemic myocardium, both indicating the 
hemodynamic relevance of a coronary stenosis. Various studies have demonstrated 
a high diagnostic performance of CMR in comparison with CA [2, 8, 9]. Nevertheless, 
no study has – to the best of our knowledge – directly compared these two non-
 6 
invasive imaging modalities, i.e., low-dose CTCA and CMR, with regard to their 
diagnostic performance in the same patient population.  
The purpose of this study was to compare the diagnostic performance of low-
dose CTCA and perfusion-CMR with LGE as well as combinations thereof for the 
diagnosis of significant CAD in one patient population taking CA as the standard of 
reference. 
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Materials and Methods 
 
Study population 
We prospectively screened 55 consecutive patients with known or suspected 
CAD undergoing elective CA. The clinical decision to perform CA was based on the 
history and the symptoms of the patient as well as on the results from exercise stress 
tests. The patients were asked to participate in this study and written informed 
consent was obtained. Patients were excluded if they had previous coronary artery 
bypass graft (n=3), impaired renal function (n=2), known hypersensitivity to contrast 
medium used in CMR or CTCA (n=0), heart rate > 70 bpm being not feasible for 
prospective ECG-gating [10] (n=2), contraindications for adenosine (second or third 
AV-block, sick sinus syndrome, symptomatic bradycardia, severe asthma or 
obstructive pulmonary disease; n=1) or to MR (implanted electronic devices, metallic 
foreign bodies in the eye, claustrophobia, and others according to local regulations 
and manufacturer’s recommendations; n=4). Thus, a total of 43 patients (9 female, 
mean age 63 ± 9 years, range 41-76 years) could be enrolled in this study (Figure 1). 
Patient characteristics are summarized in Table 1. Of the 36/43 (84%) patients who 
had stress-ECG testing before CA, 21/36 (58%) had signs of ischemia, 11/36 (31%) 
had no signs of ischemia and in 4/36 (11%) patients, results of stress-ECG testing 
remained inconclusive. Twenty-seven of the 43 patients (63%) were receiving oral β 
blockers as part of their baseline treatment. 
All low-dose CTCA and CMR examinations were performed within one day. 
The median time interval between low-dose CTCA/CMR and CA was 20 days (range 
1 to 47 days). 
 The study protocol was approved by the local institutional review board, all 
patients gave written informed consent. 
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Low-dose CTCA 
 All CT examinations were performed on a dual-source CT machine (Somatom 
Definition, Siemens Healthcare, Forchheim, Germany) using prospective ECG-
gating. All patients received a single 2.5-mg dose of sublingual isosorbide dinitrate 
(Isoket, Schwarz Pharma). No additional beta-blockers were given prior to CT. Eighty 
to 100 ml of contrast medium (iopromidum, Ultravist 370, Bayer Schering Pharma, 
Berlin, Germany) were administered at a flow rate of 5-6 ml/s, followed by 50ml of a 
20% contrast agent/80% saline solution mixture. Contrast agent was applied using a 
dual-head power injector (Stellant, Medrad, Inianola, USA) and was controlled by 
bolus-tracking using a region-of-interest in the ascending aorta (attenuation threshold 
120HU). Data were acquired in the cranio-caudal direction during mid-inspiration 
using the parameters: detector collimation, 2×32×0.6 mm; slice acquisition, 2×64×0.6 
mm by means of a z-flying spot; gantry rotation time, 0.33 s. Attenuation-based tube 
current modulation was used with a reference tube current-time product set at 190 
mAs per rotation. The data acquisition window was set at 70% of the R-R interval; the 
temporal resolution was 83 ms. Patients with a body mass index (BMI) ≥ 25 kg/m2 (n 
= 30) were examined with a tube voltage of 120 kV; patients with a BMI < 25 kg/m2 (n 
= 12) with 100 kV [10]. Low-dose CTCA images were reconstructed with a slice 
thickness of 0.6 mm, using a medium smooth-tissue convolution kernel (B30f). If the 
artery segment was calcified, additional reconstructions were performed using a 
sharp-tissue convolution kernel (B45f) to compensate for blooming artifacts. All 
images were anonymized and transferred to an external workstation (Multi-Modality 
Workplace, Siemens Healthcare) for data analysis. 
 
Low-dose CTCA Data Analysis 
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 Low-dose CTCA data analysis was performed by two independent radiologists 
who were both blinded to the clinical history and to the results from any other test 
(including CA and CMR). All images were evaluated using transverse source images 
and multi-planar reformations. All segments with a diameter ≥ 1 mm at their origin 
were included. Vessel segments distal to occlusions were excluded from analysis. 
 Coronary segments were defined according to a scheme proposed by the 
American Heart Association [11]. The intermediate artery was designated as 
segment 16, if present, and together with the left main artery was considered to 
belong to the left anterior descending coronary artery (LAD). 
 First, both readers independently rated the image quality of each coronary 
segment as being diagnostic or non-diagnostic. Reasons for non-diagnostic image 
quality were assigned to motion or stair step artifacts, image noise, severe vessel 
wall calcifications, or insufficient contrast attenuation. 
 Then, both readers independently evaluated all coronary segments for the 
presence or absence of significant stenoses, defined as luminal diameter narrowing 
>50% and >70% respectively. Segments containing stents were rated as either 
patent or non-patent. In case of disagreement, a consensus reading was appended 
one week after the initial read-out. 
 
Cardiac magnetic resonance 
 All CMR studies were performed on a 1.5-T clinical MR system (Achieva, 
Philips Medical Systems, Best, the Netherlands). Dedicated cardiac phased-array 
receiver coils were used for signal reception (five elements). All data were acquired 
during breath hold in end-inspiration. The true short-axis of the left ventricle was 
determined from a series of scout images. Three representative short-axis sections 
were obtained, one each in the basal, mid-ventricular, and apical region of the left 
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ventricle according to the standardized 17-segment model of the American Heart 
Association [12]. Pharmacological stress was applied using adenosine which was 
administered intravenously at 140 µg per kilogram of body weight over 2.5 min under 
ECG, oxygen-saturation and blood pressure monitoring. Acquisition of perfusion-
CMR images was started immediately after the injection of gadobutrolum (Gadovist® 
1,0; Bayer AG, Zurich, Switzerland). Contrast media was dosed at 0.1 mmol per 
kilogram of body weight using a power injector (MR Spectris; Medrad, Pittsburgh, Pa) 
at an injection rate of 5 ml/sec, followed by a 40-mL saline flush. Ten minutes after 
stress perfusion imaging, a second bolus of 0.1 mmol gadobutrolum was injected and 
rest perfusion images were obtained with the same orientation and position as in 
stress-perfusion imaging. A delay of 10 min after the stress-perfusion examination 
allowed residual gadobutrolum to be washed out from the myocardium. K-t sensitivity 
encoding (SENSE) perfusion-CMR imaging was used in combination with a 
saturation recovery gradient-echo pulse sequence for both of these sequences 
(repetition time/echo time, 3.1/1.1 ms; flip angle, 20°; saturation pre-pulse delay, 110 
ms; partial Fourier sampling; acquisition window, 120 ms; section thickness, 10 mm; 
k-t factor of five with 11 k-t interleaved training profiles; effective acceleration, 3.7; 
three sections acquired sequentially during a single R-R interval), as previously 
shown [13-15]. High-spatial resolution perfusion-CMR was performed with an in-
plane resolution of 1.25 x 1.25 mm. 
Ten minutes after rest perfusion, late gadolinium enhancement (LGE) images 
were acquired in continuous short-axis view using an inversion-recovery gradient-
recalled echo MR sequence with the following parameters: field of view, 350–400 
mm; repetition time/echo time, 7.4/4.3 ms; inversion time, 200–350 ms; flip angle, 
20°; matrix, 240 x 240; slice thickness, 10 mm. The inversion time was optimized 
individually to null the signal from normal myocardium. 
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CMR Data Analysis 
 CMR data analysis was performed on the commercially available ViewForum 
(Philips, Best, Netherlands) by two different, independent radiologists who were both 
blinded to the clinical history and to the results from any other test (including CA and 
low-dose CTCA). In case of disagreement between the readers, a consensus reading 
was appended after one week.  
 Perfusion-CMR as well as LGE images were evaluated by visual analysis in 
each segment of a 16-segment model (17-segment American Heart Association 
model [12] minus the apical segment) and graded using a scale from 0 to 3 (0: 
normal, 1: probably normal, 2: probably abnormal, 3: definitely abnormal), as 
previously shown [15]. Myocardial territories were assigned to the three major 
coronary arteries according to standard definitions [12] and were analyzed for the 
presence of hemodynamically relevant CAD using three different approaches: 
1) perfusion-CMR alone (PERF), 
2) LGE alone, and 
3) Perfusion-CMR combined with LGE according to the following scheme: 
Segments were considered to have a perfusion defect if a) late gadolinium 
enhancement was present and/or b) a perfusion deficit was found in stress-
perfusion but not in rest-perfusion [16] (COMB). 
 
Catheter coronary angiography 
 Biplane conventional CA was performed according to standard techniques. 
The angiograms were evaluated by an experienced observer who was blinded to the 
results from both low-dose CTCA and CMR. The coronary arteries were subdivided 
according to the same scheme used for CTCA [11] and were quantitatively assessed 
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with the use of an automated edge-detection system (Xcelera 1.2, Philips Medical 
Systems, Best, The Netherlands). Vessel diameter measurements were performed 
on two different image planes and included the diameter of the reference vessel 
(proximal and distal to the stenosis), the minimal luminal diameter and the extent of 
stenosis (defined as the diameter of the reference vessel minus the minimal luminal 
diameter, divided by the reference diameter and multiplied by 100). A significant 
stenosis was defined as a diameter reduction of >50%. 
 
Statistical analysis 
Quantitative data are expressed as means ± standard deviations and 
categorical data are given in proportions and percentages. Analysis was performed 
on an intent-to-diagnose basis: Segments with a non-diagnostic image quality at 
CTCA were rated as positive for disease. Sensitivity, specificity, positive (PPV), and 
negative predictive value (NPV) as well as accuracy were obtained from contingency 
tables; their 95% confidence intervals (CI) were calculated from binomial expression. 
CA served as the standard of reference. 
Additionally to LGE, PERF, COMB and CTCA alone, the following combinations were 
tested: 
1) Low-dose CTCA in combination with perfusion-CMR, 
2) low-dose CTCA in combination with LGE, and 
3) low-dose CTCA in combination with perfusion-CMR and LGE. 
For these combinations, a patient or artery was classified as being positive for 
disease if any of the tests was positive. 
Agreement between methods was assessed by using unweighted Cohen’s 
kappa statistics. A p-value <0.05 was considered to indicate a significant difference. 
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Statistical analyses were performed using commercially available software (SPSS, 
release 15.0, Inc., Chicago, IL). 
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Results 
 
Conventional Coronary Angiography 
 CA revealed >50% diameter stenoses in 114/688 segments (16.6%) 
corresponding to 68/129 (57.7%) coronary arteries of 29/43 (70%) patients (Figure 
1). Stenoses >70% diameter were depicted in 85/688 (12.4%) segments 
corresponding to 57/129 (44.2%) coronary arteries in 28/43 (65%) patients.  
 
Low-dose CTCA 
 During low-dose CTCA, all patients were in sinus rhythm; the average heart 
rate was 61±7 bpm (range 43–69 bpm).  
 Of the 688 possible coronary artery segments, 111 (16.3%) segments were 
not present or were less than 1mm in diameter at their origin and could therefore not 
be included into analysis.  Eight (1.2%) segments were located distally to a coronary 
occlusion. Hence, 569/688 (82.7%) segments were included into the analysis. 
Image quality of low-dose CTCA was diagnostic in 561/569 (98.6%) segments 
in 40/43 (93%) patients, comparable to previous reports ([6, 17]). Five segments 
were not assessable due to motion artifacts and three segments were not assessable 
due to severe vessel wall calcification. No stair step artifacts, image noise, or 
insufficient contrast attenuation were found as cause of non-diagnostic image quality 
in the remaining 561 segments.  
 Low-dose CTCA revealed stenoses >50% in 127/561 (22.6%) segments, 
corresponding to 72/129 (55.8%) coronary arteries in 30/43 (69.8%) patients (Figure 
1). Thirty of these stenotic arteries were located in the LAD, 20 in the LCX, and 22 in 
the RCA. Stenoses of >70% were depicted in 86/561 (15.3%) segments, 
corresponding to 62/129 (48.1%) coronary arteries in 29/43 (67%) patients. 
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CMR 
After adenosine-injection, no adverse effects leading to discontinuation of 
CMR were observed. Image quality of perfusion-CMR and LGE images was 
diagnostic in all myocardial segments of all patients. Myocardial defects were found 
in 140/688 (20.3%) segments corresponding to the territories of 57/129 (44.2%) 
coronary arteries in 26/43 (60.5%) patients (Figure 1). Nineteen of the arteries 
positive for CAD were assigned to the LAD, 16 to the LCX, and 22 to the RCA. 
 
Diagnostic Performance 
Low-dose CTCA 
 Sensitivity, specificity, NPV, PPV, and accuracy of low-dose CTCA for the 
detection of coronary stenoses in the artery-based analysis were 95.6%, 88.5%, 
94.7%, 90.3%, and 92.2%, respectively, and 100%, 92.9%, 100%, 96.7%, and 
97.7%, respectively, in the patient-based analysis (Table 2) when taking <50% 
stenosis as cutoff value. One false-positive rating occurred in a patient having a less 
than 50% stenosis according to CA in the proximal LAD. At low-dose CTCA, this 
stenosis was judged to be significant (Figure 2). When the threshold is increased to 
>70% for significant stenosis, the values for diagnostic accuracy of CTCA slightly 
decrease as now two patients are overestimated by low-dose CTCA as shown in 
Table 3.  
 Overall agreement between low-dose CTCA and CA for the detection of 
coronary stenoses was 92.2% (kappa 0.8) and 97.7% (kappa 0.95), respectively, in 
the artery- and patient-based analysis. 
 
CMR 
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The sensitivity, specificity, NPV, PPV, and accuracy of perfusion-CMR 
combined with LGE images in the artery-based analysis was 69.1%, 83.6%, 70.8%, 
82.5%, and 76%, respectively, and 89.7%, 100%, 82.4%, 100%, and 93%, 
respectively, in the patient-based analysis (Table 2). Adding LGE to perfusion-CMR 
showed an increase in sensitivity and NPV and was based on the detection of 
significant CAD in two patients with no perfusion deficits but myocardial infarction 
(Figure 3). When the threshold for significant stenosis is raised to <70%, the 
sensitivity and NPV of CMR slightly increases as the specificity and PPV slightly 
decrease as shown in Table 3.  
Overall agreement between perfusion-CMR combined with LGE images and 
CA was 76% (kappa 0.52) and 93% (kappa 0.85), respectively, in the artery- and 
patient-based analysis. 
 
Combination of low-dose CTCA and CMR 
 Combinations of low-dose CTCA and perfusion-CMR and/or LGE revealed 
minor increases in sensitivity and NPV as compared to low-dose CTCA alone. Values 
for specificity, PPV and accuracy decreased at the same time. None of the changes 
in diagnostic performance as compared to that of low-dose CTCA alone was 
significant (see Table 2 and Table 3). 
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Discussion 
This study is the first to directly compare the diagnostic performance of low-
dose CTCA and CMR for the detection of significant CAD in one patient population. 
Taking CA as the standard of reference, low-dose CTCA outperformed CMR with 
regard to sensitivity and NPV. On the other hand, CMR was more specific and had a 
higher PPV than did low-dose CTCA. Any combination of the two non-invasive 
imaging tests did not improve the diagnostic performance as compared to that of low-
dose CTCA alone. 
 
Low-dose CTCA 
CTCA using prospective ECG-gating was recently shown to be feasible in 
selected patients having a regular heart rate yielding radiation dose values as low as 
1-4mSv [6]. The diagnostic performance of CTCA known from previous single-source 
and dual-source 64-slice CT studies conducted in the retrospective ECG-gating 
mode [3, 4] could be maintained using the low-dose technique. The comparable 
diagnostic accuracy of CTCA as compared to CA has been shown in previous 
studies and could again be confirmed by our results [3, 6, 18, 19]. The most 
important clinical value of CTCA derives from its high sensitivity and NPV, allowing to 
reliably ruling-out CAD with the non-invasive test. On the other hand, specificity and 
PPV of CTCA are known to be lower, usually because of false-positive ratings 
occurring in the presence of severe vessel wall calcifications. These performance 
characteristics of CTCA could be confirmed in this study. In one patient, a heavily 
calcified stenosis at the origin of the LAD was overestimated with low-dose CTCA as 
being significant, whereas CA only showed a stenosis less than 50%. A total of two 
patients were overestimated with low-dose CTCA when taking >70% as the cutoff 
value for significant stenosis. Overestimation of stenosis grading must not be 
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considered a specific drawback of prospective ECG-gating itself [20], but similarly 
occurs with retrospective ECG-gating in the helical mode [3, 4]. 
 
CMR 
First pass perfusion under rest and adenosine-induced stress is a widely 
accepted CMR-technique for the detection of reduced myocardial blood flow. In 
addition to perfusion-CMR, LGE images are also acquired and help in the detection 
and quantification of infarcted myocardium. Thus, it is the rule to combine these two 
CMR-techniques for improving the non-invasive detection of CAD [16]. It is important 
however to recognize that LGE can be caused by other diseases apart from CAD, 
such as hypertrophic or dilated cardiomyopathy [21, 22]. Also, unrecognized 
myocardial infarction as depicted by LGE can occur as the result of a spontaneous 
thrombolysis and recannulation of an acute coronary lesion [23]. On the other hand, 
coronary stenosis in patients with CAD not necessarily leads to scarification of the 
myocardium, which is underlined by the low sensitivity of LGE imaging in our patient 
cohort.  
Our study results regarding perfusion-CMR with LGE are in line with the data 
reported in the literature [24]. Most importantly, CMR showed an excellent specificity 
and PPV for the diagnosis of hemodynamically relevant CAD. On the other hand, a 
relatively low sensitivity and NPV was found, indicating the above stated fact that not 
every “morphologic” stenosis >50% irrevocably leads to a perfusion defect in the 
corresponding myocardial segment. When raising the threshold for significant 
stenosis to >70%, patients with coronary artery stenosis between 51% and 70% with 
ischemia as depicted on CMR are now rated to be false-positive. Therefore, the slight 
increase in sensitivity and NPV of CMR is accompanied by a slight decrease in 
specificity and PPV.  
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Combining low-dose CTCA and CMR 
It is known that the morphological assessment of a coronary lesion with CA or 
CTCA does not necessarily correlate with the impairment in myocardial blood flow 
caused by the stenosis. Owing to the performance characteristics of low-dose CTCA, 
patients with no coronary stenoses can be safely discharged without further testing. 
On the other hand, patients with obstructive lesions at CTCA should undergo a 
functional test such as CMR for evaluating the hemodynamic relevance of the 
stenosis. CMR might qualify as a second line imaging technique in patients with non 
diagnostic coronary artery segments on low-dose CTCA. The three patients in our 
study which had one or more non-diagnostic segments all had other significant 
stenoses in different segments of the same vessel, therefore not influencing the 
results of diagnostic accuracy. In certain cases, where low-dose CTCA is not 
diagnostic however, CMR can help to confirm or exclude CAD.  
Thus, we did expect that the strengths and weaknesses of the two imaging 
tests would counterbalance each other. However, no combination between low-dose 
CTCA and perfusion-CMR and/or LGE did lead to a relevant increase in the 
diagnostic performance when compared to CTCA alone. This study result could be 
caused by the known variability in the coronary artery blood supply to myocardial 
segments [25]. Another, more probable explanation is the purely morphoanatomic 
nature of our reference standard. 
 
Limitations 
The number of included patients was relatively low. Our patients were referred 
for CA and as such represent a selected patient population. The cohort was 
characterised by a relatively high prevalence of CAD that may have resulted in an 
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overestimation of the ability of DSCT to detect and to rule out stenoses [26]. Thus, 
our study results may not be transferred to a more unselected group of patients. 
Further studies are needed to confirm our results in a larger and more homogeneous 
patient cohort. Secondly, as mentioned above, we compared a functional imaging 
test taking a morphological test as the reference standard without additional 
functional assessment such as fractional flow reserve. This may underestimate the 
true diagnostic performance of CMR for the diagnosis of hemodynamically relevant 
CAD. On the other hand, a comparison with CA is the standard in the majority of 
studies assessing the value of non-invasive cardiac testing. 
Finally, CMR images were analyzed purely visually using a previously 
described algorithm [2, 14-16]. No semi-quantitative analysis of perfusion-CMR was 
performed. However, most studies investigating the diagnostic accuracy of CMR for 
the detection of CAD utilize purely visual evaluation [2, 14-16, 27] and the majority of 
centers continue to use visual analysis for the assessment of clinical myocardial 
perfusion scans [28]. Comparing the rest and stress scans together on a viewing 
platform allows the recognition of perfusion defects and discrimination from artifacts, 
as previously shown [29]. Recognition of artifacts is critical for accurate analysis of 
scans because artifacts with rapid image acquisition usually manifest themselves as 
dark subendocardial rims and may mimic perfusion defects. 
 
Conclusion 
Compared to CA, low-dose CTCA outperforms CMR with regard to sensitivity 
and NPV, whereas CMR is more specific and has a higher PPV than low-dose 
CTCA. Combined approaches of low-dose CTCA and CMR did not improve the 
performance of CTCA alone, most probably because of the use of a purely 
morphological imaging test as the standard of reference. 
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Table 1: Patient demographics. 
 
Males 34 (79%) 
Females 9 (21%) 
Age (years) 64 ± 9 
Body mass index (kg/m2) 28 ± 4 
Cardiovascular risk factors  
Hypertension 31 (72%) 
Smoker 13 (30%) 
Hyperlipidemia 30 (70%) 
Family history 10 (23%) 
Diabetes 8 (19%) 
Symptoms  
Dyspnea 23 (54%) 
Atypical chest pain 5 (12%) 
Typical chest pain 22 (51%) 
History of myocardial infarction 9 (21%) 
Previous percutaneous coronary intervention 7 (16%) 
oral β blockers part of baseline treatment 27 (63%) 
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Table 2: Diagnostic performance of low-dose CTCA, CMR, and combinations thereof in comparison with catheter coronary 
angiography. (Cut-off value for CA: >50%) 
 
 Sensitivity (CI;n) 
Specificity 
(CI;n) 
NPV 
(CI;n) 
PPV 
(CI;n) 
Accuracy 
(CI;n) 
Per-artery analysis      
 CT      
 Low-dose CTCA 95.6%* (90-100;65/68) 88.5% (80-97;54/61) 94.7%* (88-100;54/57) 90.3% (83-98;65/72) 92.2% (87-97;119/129) 
       
 CMR      
 PERF 60.3% (48-73;41/68) 86.9% (78-96;53/61) 66.3% (55-77;53/80) 83.7% (72-95;41/49) 72.9% (65-81;94/129) 
 LGE 26.5% (15-38;18/68) 93.4% (86-100;57/61) 53.3% (43-63;57/107) 81.8% (63-100;18/22) 58.1% (49-67;75/129) 
 COMB 69.1%* (68-81;47/68) 83.6% (74-94;51/61) 70.8%* (60-82;51/72) 82.5% (72-93;47/57) 76% (68-84;98/129) 
       
 CT and CMR      
 CTCA/LGE 95.6% (90-100;65/68) 86.9% (78-96;53/61) 94.6% (88-100;53/56) 89% (81-97;65/73) 91.5% (86-97;118/129) 
 CTCA/PERF 97.6% (92-100;66/68) 78.7% (68-90;48/61) 96% (90-100;48/50) 83.5% (75-92;66/79) 88.4% (83-94;114/129) 
  CTCA/COMB 97.6% (92-100;66/68) 78.7% (68-90;48/61) 96% (90-100;48/50) 83.5% (75-92;66/79) 88.4% (83-94;114/129) 
Per-patient analysis      
 CT      
 Low-dose CTCA 100% (98-100;29/29) 92.9% (76-100;13/14) 100% (96-100;13/13) 96.7% (89-100;29/30) 97.7% (92-100;42/43) 
       
 CMR      
 PERF 82.8% (67-98;24/29) 100% (96-100;14/14) 73.7% (51-96;14/19) 100% (98-100; 24/24) 88.4% (78-99;38/43) 
 LGE 51.7% (32-72;15/29) 100% (96-100;14/14) 50% (30-70;14/28) 100% (97-100;15/15) 67.4% (52-83;29/43) 
 COMB 89.7% (77-100;26/29) 100% (96-100;14/14) 82.4% (61-100;14/17) 100% (98-100;26/26) 93%  (84-100;40/43) 
       
 CT and CMR      
 CTCA/LGE 100% (98-100;29/29) 92.9% (76-100;13/14) 100% (96-100;13/13) 96.7% (89-100;29/30) 97.7% (92-100;42/43) 
 CTCA/PERF 100% (98-100;29/29) 92.9% (76-100;13/14) 100% (96-100;13/13) 96.7% (89-100;29/30) 97.7% (92-100;42/43) 
  CTCA/COMB 100% (98-100;29/29) 92.9% (76-100;13/14) 100% (96-100;13/13) 96.7% (89-100;29/30) 97.7% (92-100;42/43) 
NPV: negative predictive value, PPV: positive predictive value, CI: 95%-confidence interval; PERF: adenosine stress-/rest-perfusion; LGE: late gadolinium-enhancement; COMB: 
adenosine stress-/rest-perfusion and late gadolinium-enhancement; CTCA: computed tomography coronary angiography. * Differences are significant (p<0.05). 
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Table 3: Diagnostic performance of low-dose CTCA, CMR, and combinations thereof in comparison with catheter coronary 
angiography. (Cut-off value for CA: >70%) 
 
 Sensitivity (CI;n) 
Specificity 
(CI;n) 
NPV 
(CI;n) 
PPV 
(CI;n) 
Accuracy 
(CI;n) 
Per-artery analysis      
 CT      
 Low-dose CTCA 89.4% (80-98;51/57) 84.7% (75-93;61/72) 91% (83-98;61/67) 82.2% (71-92;51/62) 86.8% (80-93;112/129) 
       
 CMR      
 PERF 61.4% (47-74;35/57) 80.5% (70-90;58/72) 72.5% (62-82;58/80) 71.4% (57-85;35/49) 72% (63-80;93/129) 
 LGE 31.5% (18-44;18/57) 94.4% (88-100;68/72) 63.5% (53-73;68/107) 81.8% (63-100;18/22) 66.6% (58-75;86/129) 
 COMB 71.9% (59-84;41/57) 77.7% (67-88;56/72) 77.7% (67-88;56/72) 71.9% (59-84;41/57) 75.1% (67-83;97/129) 
       
 CT and CMR      
 CTCA/LGE 91.2% (83-99;52/57) 81.9% (72-91;59/72) 92.1% (84-99;59/64) 80% (69-90;52/65) 86% (79-92;111/129) 
 CTCA/PERF 94.7% (88-101;54/57) 73.6% (62-84;53/72) 94.6% (87-101;53/56) 73.9% (63-84;54/73) 82.9% (76-89;107/129) 
  CTCA/COMB 94.7% (88-101;54/57) 72.2% (61-83;52/72) 94.5% (87-101;52/55) 72.9% (62-83;54/74) 82.1% (75-89;106/129) 
Per-patient analysis      
 CT      
 Low-dose CTCA 96.4% (87-105;27/28) 86.6% (66-107;13/15) 92.8% (75-109;13/14) 93.1% (82-104;27/29) 93% (84-101;40/43) 
       
 CMR      
 PERF 82.1% (66-98;23/28) 93.3% (77-109;14/15) 73.6% (51-96;14/19) 95.8% (85-105;23/24) 86% (74-97;37/43) 
 LGE 50% (29-70;14/28) 93.3% (77-109;14/15) 50% (29-70;14/28) 93.3% (77-109;14/15) 65.1% (49-80;28/43) 
 COMB 89.2% (76-102;25/28) 93.3% (77-109;14/15) 82.3% (61-103;14/17) 96.1% (86-105;25/26) 90.6% (80-100;39/43) 
       
 CT and CMR      
 CTCA/LGE 96.4% (87-105;27/28) 86.6% (66-107;13/15) 92.8% (75-109;13/14) 93.1% (82-104;27/29) 93% (84-101;40/43) 
 CTCA/PERF 96.4% (87-105;27/28) 86.6% (66-107;13/15) 92.8% (75-109;13/14) 93.1% (82-104;27/29) 93% (84-101;40/43) 
  CTCA/COMB 96.4% (87-105;27/28) 86.6% (66-107;13/15) 92.8% (75-109;13/14) 93.1% (82-104;27/29) 93% (84-101;40/43) 
NPV: negative predictive value, PPV: positive predictive value, CI: 95%-confidence interval; PERF: adenosine stress-/rest-perfusion; LGE: late gadolinium-enhancement; COMB: 
adenosine stress-/rest-perfusion and late gadolinium-enhancement; CTCA: computed tomography coronary angiography. * Differences are significant (p<0.05). 
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Figure Legends 
 
Fig. 1 —Study workflow. 
 
Fig. 2 — 76-year-old male with clinical suspicion of CAD. CA revealed a non-
significant stenosis at the origin of the LAD (a, arrow). At low-dose CTCA, this 
stenosis was judged as being significant (b, arrowhead). Perfusion-CMR showed no 
perfusion deficit (c, adenosine stress). No late gadolinium enhancement was found 
(not shown). 
 
Fig. 3 — 60-year-old male with clinical suspicion of CAD. CA showed a significant 
stenosis of the distal LCX (a, arrowheads) and occlusion of the first posterolateral 
branch (a, arrow). Low-dose CTCA confirmed the significant stenosis (b, arrowheads) 
and occlusion (b, arrow). Stress-(c) and rest-perfusion-CMR (d) revealed no 
perfusion deficit. Late gadolinium enhancement was found in anterolateral and 
partially in inferolateral myocardial segments, corresponding to the LCX territory 
(arrowheads, e). 
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Figures: 
 
Fig. 1—Study workflow 
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Fig. 2 —76-year-old male with clinical suspicion of CAD. CA revealed a non-significant stenosis at the origin of the LAD (a, arrow). At 
low-dose CTCA, this stenosis was judged as being significant (b, arrowhead). Perfusion-CMR showed no perfusion deficit (c, 
adenosine stress). No late gadolinium enhancement was found (not shown). 
 
   
a b c 
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Fig. 3 — 60-year-old male with clinical suspicion of CAD. CA showed a significant stenosis of the distal LCX (a, arrowheads) and 
occlusion of the first posterolateral branch (a, arrow). Low-dose CTCA confirmed the significant stenosis (b, arrowheads) and 
occlusion (b, arrow). Stress-(c) and rest-perfusion-CMR (d) revealed no perfusion deficit. Late gadolinium enhancement was found in 
anterolateral and partially in inferolateral myocardial segments, corresponding to the LCX territory (arrowheads, e). 
 
 
 
a b c 
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